PENTETATE ZINC TRISODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pentetate zinc trisodium and what is the scope of patent protection?
Pentetate zinc trisodium
is the generic ingredient in one branded drug marketed by Hameln Pharma Plus and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for PENTETATE ZINC TRISODIUM
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 9 |
| Clinical Trials: | 1 |
| Patent Applications: | 97 |
| What excipients (inactive ingredients) are in PENTETATE ZINC TRISODIUM? | PENTETATE ZINC TRISODIUM excipients list |
| DailyMed Link: | PENTETATE ZINC TRISODIUM at DailyMed |
Recent Clinical Trials for PENTETATE ZINC TRISODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 1/Phase 2 |
US Patents and Regulatory Information for PENTETATE ZINC TRISODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hameln Pharma Plus | PENTETATE ZINC TRISODIUM | pentetate zinc trisodium | SOLUTION;INHALATION, INTRAVENOUS | 021751-001 | Aug 11, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
